To read this article in full you will need to make a payment
Purchase one-time access:
Academic and PersonalCorporate R&D ProfessionalsOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Urology FocusAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model.J Sex Med. 2013; 10: 738-746
- Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model.J Sex Med. 2016; 13: 22-32
- The effect of low-intensity extracorporeal shockwave therapy in an obesity-associated erectile dysfunction rat model.BJU Int. 2018; 122: 133-142
- In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy.J Sex Med. 2017; 14: 493-501
- Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?.Nat Rev Urol. 2017; 14: 593-606
- Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction.Eur Urol. 2010; 58: 243-248
- A phase 2 randomized trial to evaluate different dose regimens of low-intensity extracorporeal shockwave therapy for erectile dysfunction: clinical trial update.Eur Urol Focus. 2018; 4: 336-337
- Is low-intensity shockwave therapy for erectile dysfunction ready for clinical practice?.IJIR. 2018; https://doi.org/10.1038/s41443-018-0081-z
- Effect of low-energy linear shockwave therapy on erectile dysfunction-a double-blinded sham-controlled, randomized trial.J Sex Med. 2017; 14: 106-112
- Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective randomized, double-blinded, placebo controlled study.Int J Urol. 2014; 21: 1041-1045
- Low-intensity extracorporeal shock wave therapy—a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy.J Sex Med. 2012; 9: 259-264
- Twelve-month efficacy and safety of low-intensity shockwave therapy for erectile dysfunction in patients who do not respond to phosphodiesterase type 5 inhibitors.Sex Med. 2016; 4: e225-e232
- Low-intensity extracorporeal shockwave therapy can improve erectile function in patients who failed to respond to phosphodiesterase type 5 inhibitors.Am J Mens Health. 2017; 11: 1781-1790
- Safety and efficacy of low intensity shockwave (LISW) in patients with erectile dysfunction.Int Braz J Urol. 2015; 41: 967-974
- Penile low intensity shock wave treatment is able to shift PDE5i nonresponders to responders: a double-blind sham controlled study.J Urol. 2016; 195: 1550-1555
- EAU guidelines on erectile dysfunction, premature ejaculation, penile curvature and priapism.Eur Assoc Urol. 2016;
- Erectile dysfunction: AUA guideline.J Urol. 2018; 200: 633-641
Article Info
Publication History
Published online: February 15, 2019
Identification
Copyright
© 2019 Published by Elsevier B.V. on behalf of European Association of Urology.
